dc.relation.reference | Aitman TJ. Genetics medicine and obesity. N. Engl. J. Med. 2003; 348:2138-2139
Atsuko M, Kazuya Y, Masafumi K, et al. J Bio Chemistry 2006; 281(8):5246-5257
Banerji M, Lebovitz H. Insulin sensitive and insulin resistant variants in IDDM. Diabetes 1989; 38:784-792
Barrio R, Bellanne-Chantelot C, Moreno JC, et al. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002; 87:2532-2539
Bingham C, Bulman MP, Ellard S, et al. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 2001; 68:219-224
Bogardus C, Lillioja S, Mott DM, et al. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol. 1985; 248:E286-E291
Byrne MM, Sturis J, Fajans SS, et al. Altered insulin secretory response to glucose in subjects with a mutation in the MODY 1 gene on chromosome 20. Diabetes 1995; 44: 699-704
Canter AB, Krischer JP, Cuthbertson DD, et al. Age and family relationship accentuate the risk of IDDM in relatives of patients with insulin dependent diabetes. J. Clin. Endocrinol. Metab. 1995; 80: 3739-3743
Cao H, Shorey S, Robinson J, et al. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Hum Mutat 2002; 20:478-479
Carlos A. AS, Eduardo RR, et al. Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population. J Clin Endocrinol Metab 2001; 86 No1:220-226
Cecile H, Melanie F, Sarah C, et al. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1beta/MODY5 mutations. HMG 2006
Carette C, Vaury C, Barthelemy A, et al. Exonic Duplication of the Hepatocyte Nuclear Factor-1{beta} Gene (Transcription Factor 2, Hepatic) as a Cause of Maturity Onset Diabetes of the Young Type 5. J Clin Endocrinol Metab 2007; 92(7):2844-2847
Duncan SA, Navas MA, Dufort D, et al. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998; 281:692-695
Ewan RP, Sylvia FB, Anna MS, et al. Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene. PLOS Medicine 2007; Vol 4 Issue 4 e118:001-0010
Fajans SS, Conn JW. Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes 1960; 9: 83
Fajans SS. MODY: a model for understanding the pathogeneses and natural history of type II diabetes. Horm Metab Res 1987; 19: 591-599
Fajans SS, Brown B. Adminstration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity- onset diabetes of the young. Diabetes Care 1993; 16: 1254-1261
Fajans SS, Bell GI, Bowden DW, et al. Maturity-onset diabetes of the young. Life Sci 1994; 55: 413-422
Fajans SS, Bell GI, Herman WH, et al. Natural history, genetics and pathogenesis of HNF-4α/MODY1: a 40-year prospective study of the RW pedigree. In: Matschinsky FM, Magnuson MA, eds. Vol. 15 of Frontiers in diabetes: molecular pathogenesis of MODYs. Basel, Switzerlan: Karger, 2000:1-15
Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345:971-980
Frayling TM, Bulman MP, Appleton M, et al. A rapid screening method for hepatocyte nuclear factor 1 alpha frameshift mutations; prevalence in maturity-onset diabetes of the young and late-onset non-insulin dependent diabetes. Hum. Genet. 1997; 101:351-354
Frayling TM, Evans JC, Bulman MP, et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001; 50: S94-S100
Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356:162-164
Gloyn AL. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 2003; 22:353-362
Harper P, Clarke A. Should we test children for ‘adult’ genetic disease? Lancet 1990; 335:1205
Hattersley AT. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetics heterogeneity. Diabet. Med. 1998; 15:15-24
Helge R, Lise B, Stefan J, et al. A Hepatocyte Nuclear Factor-4α Gene (HNF4A) P2 Promoter Haplotype Linked With Late-Onset Diabetes. Diabetes 2006; 55:1899-1903
Herman WH, Fajans SS, Ortiz FJ, et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 1994; 43: 40-46
Hertz R, Magenheim J, Berman I, et al. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 1998; 392(6675):512-6
Huang W, Connor E, DelaRosa T, et al. Although DR3-DQB1 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1I0302 halotype is implicated only in beta cell autoimmunity. J. Clin. Endocrinol. Metab. 1996; 81:1-5
Jakob Ek, Sara PH, Maria L, et al. A Novel –192c/g Mutation in the Proximal P2 Promoter of the Hepatocyte Nuclear Factor-4α Gene (HNF4A) Associates With Late-Onset Diabetes. Diabetes 2006; Vol 55:1869-1873
Jap TS, Wu YC, Chiou JY, Kwok CF. A novel mutation in the hepatocyte nuclear factor-1α/MODY3 gene in Chinese subjects with early-onset Type 2 diabetes mellitus in Taiwan. Diabet. Med. 2000; 17: 390-393
Johansen A, Ek J, Mortensen HB, et al. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK and TCF1. J Clin Endocrinol Metab 2005; 90(8):4607-4614
Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371:606-609
Kristinsson SY, Thorolfsdottir ET, Talseth B. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia 2001; 44:2098-2103
Ledermann HM. Is maturity onset diabetes at young age(MODY) more common in Europe than previously assumed? Lancet 1995; 345(8950):648
Lindner TH, Njolstad PR, Horikawa Y, et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 1999; 8:2001-2008
Lorna WH, Sian E, Amanda S, et al. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Human Mol Genetics 2006; Vol 15 No.14:2216-2224
Martine V, Pharm D, Philippe F. Genetic basis of maturity-onset diabetes of the young. Endocrinol Metab Clin N Am 2006; 35:371-384
Milewski WM, Duguay SJ, Chan SJ, et al. Conservation of PDX-1 structure, function, and expression in zebrafish. Endocrinology 1998; 139:1440-1449
Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc. Nat. Acad. Sci. 2005; 102: 4807-4812
Nishigori H, Yamada S, Kohama T, et al. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 1998; 47:1354-1355
Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003; 52:2854-2860
Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am. J. Physiol. 1982; 243:E15-E30
Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003; 34:292-296
Polonsky KS, Sturis J, Bell, GI. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 1996; 334: 777-784
Porter JR, Rangasami JJ, Ellard S, et al. Asian MODY: are we missing an important diagonosis? Diabetes UK 2006; 23:1257-1260
Raeder H, Johansson S, Holm PI, et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006; 38(1):12-3.006
Rana KG, Marko ZV, Catherine SL, et al. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. J Clin Invest 2005; Vol 115 No4:1006-1015
Shaat N, Karlsson E, Lernmark A, et al. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006; 49:1545-1551
Shepherd M, Ellis I, Ahmad AM, et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabetes UK 2001; 18:417-421
Shih DQ, Dansky HM, Fleisher M, et al. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 2000; 49:832-837
Sian E. Hepatocyte nuclear factor 1 alpha (HNF-1A) mutations in maturity-onset diabetes of the young. Human Mutation 2000; 16:377-385
Sian E, Kevin C. Mutation in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Human Mutation 2006; 27(9):854-869
Sovik O, Njolstad P, Folling I, et al. Hyperexcitability to sulphonylurea in MODY 3. Diabetologia 1998; 41: 607-608
Stefan SF, Graeme IB, Kenneth SP. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345(13):971-980
Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 1997; 94:13209-13214
Stoffers DA, Ferrer J, Clarke WL, et al. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997; 17:138-9
Stoffers DA, Stanojevic V, Habener JF. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 1998; 102:232-241
Tamimi R, Steingrimsson E, Copeland NG. The NEUROD gene maps to human chromosome 2q32 and mouse chromosome 2. Genomics 1996; 34:418-421
Tattersall RB. Mild familial diabetes with dominant inheritance. Q. J. Med. 1974; 43: 339-357
Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type of diabetes in young people. Diabetes 1975; 24:44-53
Tattersall R. Maturity-onset diabetes of the young: a clinical history. Diabet. Med. 1998; 15:11-14
Turner RC, Holman RR, Matthew D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative to contribution by feedback analysis from basal plasma insulin and glucose concentration. Metabolism 1979; 28: 1086-1096
Uusitupaa MIJ, Niskanen LK, Siitonen O, et al. Ten year cardiovascular mortality in relation to risk factors abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 18: 1534-1543
Velho G, Vaxillaire M, Boccio V, et al. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 1996; 19(9):915-9
Velho G, Benque-Blanchet F, Vaxillaire M, et al. Renal proximal tubular defects associated to the MODY3 phenotype. Diabetologia 1998; 41(S1):418
Wang H, Maechler P, Antinozzi PA, et al. Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 2000; 275:35953-35959
Wendy W, Robert RG, et al. Association Testing of Variants in the Hepatocyte Nuclear Factor 4α Gene With Risk of Type 2 Diabetes in 7883 People. Diabetes 2005; Vol 54: 886-892
Wright NM, Metzger DL, et al. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. Am J Dis Child 1993; 147:607-9
Xu J Y, Dan QH, Chan V, et al. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Europ. J. Hum. Genet 2005; 13:422-427
Yamada S, Zhu Q, Aihara Y et al. Cloning of cDNA and the gene encoding human hepatocyte nuclear factor (HNF)-3β and mutation screening in Japanese subjects with maturity-onset diabetes of the young. Diabetologia 2000; 43: 121-124
Yamagata K. Regulation of pancreatic β-cell function by the HNF transcription netweek: Lessons from Maturity-Onset Diabetes of the Young (MODY). Endocrine Journal. 2003; 50: 491-499 | en |